References

1. Bruijnzeels MA, van Suijlekom-Smit LWA,van der Velden J, van der Wouden JC. The child In general practice. Rotterdam/Utrecht:Erasmus Universiteit/NIVEL,1993.

2. van der Ven-Daane I, Bruijnzeels MA, van der Wouden JC, van Suijlekom-Smit LWA. Occurrence and treatment of impetigo vulgaris in children. Huisarts Wet 1993;36:291-3.

3. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: fourth national study 1991-1992. London: Department of Health, Office of Population Censuses and Royal College of General Practitioners, 1995.

4. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992;36:287-90.

5. Van Amstel L, Koning S, van Suijlekom-Smit LWA, Oranje A, van der Wouden JC. The treatment of impetigo contagiosa, a systematic review. Huisarts Wet 2000;43:247-52.

6. Ruby RJ, Nelson JD. The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo. Pediatrics 1973;52:854-9.

7. Christensen OB, Anehus S. Hydrogen peroxyde cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm Venerol 1994;74:460-2.

8. Eells LD, Mertz PM, Piovanetti Y, Pekoe GM, Eaglstein WH. Topical antibiotic treatment of impetigo with mupirocin. Arch Dermatol 1986;122:1273-6.

9. Gould JC, Smith JH, Moncur H. Mupirocin in general practice: a placebo-controlled trial. Royal Society of Medicine: international congress and symposium series 1984;80:85-93.

10. Koning S, van Suijlekom-Smit LWA, Nouwen JL et al. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ 2002;324:203-6.

11. Morley PAR, Munot LD. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin 1988;11:142-8.

12. Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 1989;20:1083-7.

13. White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment of superficial skin infections in general practice - a comparison of mupirocin with sodium fusidate. J Infect 1989;18:221-9.

14. Jaffe GV, Grimshaw JJ. A clinical trial of hydrocortisone/ potassium hydroxyquinoline sulphate (Quinocort) in the treatment of infected eczema and impetigo in general practice. Pharmatherapeutica 1986;4:628-36.

15. Nolting S, Strauss WB. Treatment of impetigo and ecthyma. A comparison of sulconazole with miconazole. Int J Derm 1988;27:716-19.

16. Vainer G, Torbensen E. Behandling af impetigo i almen praksis. Ugeskr laeger 1986;148:1202-6.

17. Britton JW, Fajardo JE, Krafte-Jacobs B. Comparison of mupirocin and erythromycin in the treatment of impetigo. J Pediatr 1990;117:827-9.

18. Mertz PM, Marshall DA, Eaglstein WH, Piovanetti Y, Montalvo J. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol 1989;125:1069-73.

19. Bass JW, Chan DS, Creamer KM et al. Comparison of oral cephalexin, topical mupirocin, and topical bacitracin for treatment of impetigo. Pediatr Inf Dis J 1997;16:708-9.

20. Demidovich CW, Wittler RR, Ruff ME, Bass JW, Browning WC. Impetigo: current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child 1990;144:1313-15.

21. Barton LL, Friedman AD. Impetigo: A reassessment of etiology and therapy. Pediatr Dermatol 1987;4:185-8.

22. Kiani R, Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections. Eur J Clin Microbiol Infect Dis 1991;10:880-4.

23. Barton LL, Friedman AD, Portilla MG. Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy. Pediatr Dermatol 1988;5:88-91.

24. Dagan R, Bar-David Y. Comparison of amoxicillin and clavulanic acid (Augmentin) for the treatment of nonbullous impetigo. Am J Dis Child 1989;143:916-18.

25. Tack KJ, Keyserling CH, McCarty J, Hedrick JA. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. Antimicrob Agents Chemother 1997;41:739-42.

0 0

Post a comment